Zobrazeno 1 - 10
of 25
pro vyhledávání: '"329"'
Autor:
Auro Viswabandya, Hans A. Messner, Dennis Dong Hwan Kim, Jieun Uhm, Marc Poch Martell, Elizabeth Shin, Jeffrey H. Lipton, Fotios V. Michelis
Publikováno v:
Blood. 126:3139-3139
Introduction: Chronic graft versus host disease (cGVHD) is one of the major complications after allogeneic hematopoietic cell transplantation (allo-HCT). Several prognostic factors have been proposed to predict the outcomes of cGVHD including progres
Autor:
Scott C. Kogan, Geoffrey D. Wool
Publikováno v:
Blood, vol 122, iss 21
The UCSF hematology laboratory uses the Precision Biologic LA Check and LA Sure reagents for the Russell’s viper venom time (RVVT), as part of the laboratory diagnosis of a lupus anticoagulant (LA). Currently, manufacturer’s FDA-approved guidelin
Publikováno v:
Blood. 110:1310-1310
Syk kinase is central to FcR and B-cell signaling in inflammatory cells. By inhibiting syk, and thereby IgG signaling, R788 (a small molecule prodrug for biologically active R406), inhibits the downstream activation of mast cells, macrophages and B-c
Autor:
Veronika Buxhofer-Ausch, Marco Ruggeri, Tiziano Barbui, Ayalew Tefferi, Juergen Thiele, Valerio De Stefano, Maria Luigia Randi, Guido Finazzi, Elisa Rumi, Alessandro Rambaldi, Heinz Gisslinger, Silvia Betti, Francesco Passamonti, Irene Bertozzi, Francesco Rodeghiero, Alessandro M. Vannucchi, Alessandra Carobbio
Publikováno v:
Blood. 120:5128-5133
Accurate prediction of thrombosis in essential thrombocythemia (ET) provides the platform for prospective studies exploring preventive measures. Current risk stratification for thrombosis in ET is 2-tiered and considers low- and high-risk categories
Autor:
Erin Morris, John S. Holcenberg, F. Leonard Johnson, Stanton Goldman, Raymond J. Hutchinson, Jerry Z. Finklestein, Susan G. Kreissman, Elizabeth Harvey, Conrad Tou, Mitchell S. Cairo
Publikováno v:
Blood. 97:2998-3003
Standard therapy in the United States for malignancy-associated hyperuricemia consists of hydration, alkalinization, and allopurinol. Urate oxidase catalyzes the enzymatic oxidation of uric acid to a 5 times increased urine soluble product, allantoin
Autor:
Wilson I. Gonsalves, Ronald S. Go, Nidhi Tandon, John A. Lust, Amie Fonder, Surbhi Sidana, Angela Dispenzieri, Nelson Leung, Steven R. Zeldenrust, Suzanne R. Hayman, Miriam Hobbs, Shaji Kumar, Martha Q. Lacy, Robert A. Kyle, Stephen J. Russell, Yi L. Hwa, Francis K. Buadi, S. Vincent Rajkumar, David Dingli, Morie A. Gertz, Prashant Kapoor
Publikováno v:
Blood. 128:4627-4627
Introduction High dose chemotherapy and autologous stem cell transplantation (ASCT) is an effective therapy for eligible patients with newly diagnosed systemic AL amyloidosis. Dose attenuated melphalan is used in patients with older age, renal dysfun
Autor:
Muneer H. Abidi, Andy I. Chen, Tamas Masszi, Auayporn Nadamanee, Veronika Bachanova, Naomi N. H. Hunder, Patrick J. Stiff, Simonetta Viviani, Anna Sureda, Angelo Michele Carella, Dirk Huebner, Jan Walewski, Emily K. Larsen, Jerzy Holowiecki, Craig H. Moskowitz, Dzhelil Osmanov, John W. Sweetenham, Edward Agura
Publikováno v:
Blood. 126:3172-3172
Introduction The AETHERA trial is a phase 3, randomized, placebo-controlled trial (ClinicalTrials.gov #NCT01100502), which evaluated whether post-ASCT consolidation treatment with brentuximab vedotin (BV) could prevent disease progression in Hodgkin
Autor:
Genovefa A. Papanicolaou, Yao-Ting Hayden Huang, Victoria Gonzalez, Anna Kaltsas, Marina Kerpelev, Yeon Joo Lee, Seong Jin Kim
Publikováno v:
Blood. 126:3303-3303
Background: Streptococcus pneumoniae is a major cause of sepsis, pneumonia and meningitis leading to significant morbidity and mortality. Invasive pneumococcal disease (IPD) and mortality rates in cancer patients (pts) are higher than in the general
Autor:
Nicola Vianelli, Francesca Palandri, Margherita Perricone, Massimo Breccia, Nicola Polverelli, Roberto Latagliata, Emanuela Ottaviani, Michele Cavo, Giuseppe A. Palumbo, Lucia Catani, Giuliana Alimena, Francesco Merli, Giovanni Martinelli, Alessia Tieghi
Publikováno v:
Blood. 126:1614-1614
Introduction It is acknowledged that an accurate histological diagnosis may distinguish Essential Thrombocythemia (ET) from early Primary Myelofibrosis (early-PMF), which is projected to worse outcome in terms of survival and disease evolution into a
Autor:
Lucia Masarova, Taghi Manshouri, Sherry Pierce, Prithviraj Bose, Naveen Pemmaraju, Srdan Verstovsek, Naval Daver, Hagop M. Kantarjian, Jorge E. Cortes
Publikováno v:
Blood. 126:4069-4069
Introduction: Clinical characteristics of post-essential thrombocythemia/polycythemia vera myelofibrosis "post ET/PV-MF" are not well defined as for primary myelofibrosis "MF". Objective: We aimed to identify morphological, clinical and prognostic ch